WallStSmart
FTRE

Fortrea Holdings Inc.

NASDAQ: FTRE · HEALTHCARE · BIOTECHNOLOGY

$14.99
-6.78% today

Updated 2026-06-05

Market cap
$1.46B
P/E ratio
P/S ratio
0.54x
EPS (TTM)
$-4.81
Dividend yield
52W range
$4 – $19
Volume
1.3M

Fortrea Holdings Inc. (FTRE) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item202020212022202320242025
Operating cash flow$200.90M$169.80M$82.70M$168.40M$262.80M$113.50M
Capital expenditures$24.00M$26.50M$54.40M$40.30M$25.50M$25.20M
Depreciation$119.00M$166.30M$93.60M$98.00M$98.00M
Stock-based comp$23.10M$27.50M$25.40M$42.70M$58.40M$74.40M
Free cash flow$176.90M$143.30M$28.30M$128.10M$237.30M$88.30M
Investing cash flow$-161.20M$-26.20M$-54.00M$-31.80M$251.60M
Financing cash flow$-33.10M$-128.50M$-6.30M$-140.80M$-497.80M
Dividends paid
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

What is Fortrea Holdings Inc.'s revenue?

Fortrea Holdings Inc.'s trailing twelve-month revenue is $2.71B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is FTRE?

In its most recent fiscal year, FTRE ran a gross margin of 15.63%, an operating margin of -1.12%, and a net margin of -36.21%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does FTRE generate?

FTRE produced $88.30M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is FTRE's balance sheet healthy?

FTRE holds $174.60M in cash and equivalents against $1.05B in long-term debt, on $563.50M of shareholder equity. That debt is best read against the cash flow the business throws off each year.